RICHMOND, Va., September 8, 2025 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today reaffirmed its commitment to addressing the nation’s drug shortage crisis as it observes the 5th annual National Essential Medicines Shortage Awareness Day (NEMSAD). NEMSAD, held each year on September 8, raises awareness and drives bold solutions to America’s drug shortage crisis.
Today, more than 250 essential medicines remain in active shortage across the U.S., delaying treatment for patients facing cancer, infections, heart conditions, autoimmune diseases, behavioral health challenges, and more. These shortages are fueled by fragile global supply chains, sole-source manufacturing, quality breakdowns, and unpredictable crises such as pandemics, geopolitical conflict, and natural disasters.
Phlow was created to help solve this challenge. As a purpose-driven B Corp™, our purpose is to create the future of how medicines are made. Its mission is to help brilliant minds bring medicines to life through advanced development and manufacturing in America. Through innovation, partnerships, and a commitment to sustainability, Phlow is working to strengthen the nation’s medicine cabinet and ensure patients have access to life-saving treatments.
We also celebrate the momentum and progress toward solving this challenge. The recent Executive Order to operationalize the Strategic Active Pharmaceutical Ingredient Reserve (SAPIR) reflects a national commitment to resilience. When Phlow first proposed the SAPIR it was built on the belief that supply chain resilience requires more than stockpiling. It demands an active, ready-to-deploy domestic infrastructure that can respond to dynamic threats, from pandemics to geopolitical tensions, by ensuring a continuous domestic supply of essential medicines.
In 2025, Phlow expanded domestic manufacturing infrastructure in Richmond, VA, delivered more than 1.6 million vials of essential medicines to children’s hospitals, secured $37 million in Series C financing, and more than doubled our workforce to over 100 employees. These steps demonstrate real progress in strengthening America’s preparedness and ensuring reliable access to essential medicines.
For more information and resources to support National Essential Medicine Shortage Awareness Day, visit www.stoptheshortages.com.
About Phlow Corp.
Phlow, a B Corporation™, helps brilliant minds bring medicines to life through advanced development and manufacturing in America. Focused on innovations in drug substance development, Phlow supports government and private industry customers to create innovative approaches with scientific expertise, world-class manufacturing, and tech-enabled processes that propel the industry forward to a new standard as we create the future of how medicines are made. As a modern contract development and manufacturing provider, we measure our impact by increasing speed to market, reducing waste, and offering an environmentally friendly approach to manufacturing medicines that lead to healthy, resilient communities. For more, visit phlow-usa.com.